We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Technology Offers Identification, Genotyping, and Characterization of Emerging Organisms

By LabMedica International staff writers
Posted on 22 Apr 2010
A program with public health applications includes epidemiologic surveillance, monitoring of pandemic diseases, and identification of emerging or previously unknown agents.

The Plex-ID system employs a combination of molecular technologies, including polymerase chain reaction (PCR) for gene amplification and mass spectrometry analysis to characterize rapidly known and unknown organisms. More...
It is designed to address a significant unmet need by providing test results in six to seven hours instead of three or more days as required with current laboratory methods.

Plex-ID, a product of Abbott (Abbott Park, IL, USA), can identify a broad range of bacteria, viruses, fungi, and certain parasites, and provide information about drug resistance, virulence, and strain type. It has the potential to be a powerful and versatile tool for public health laboratories, according to David N. Sundwall, Ph.D., executive director, Utah Department of Health (UDH; Salt Lake City, UT, USA).

"Plex-ID addresses the complex challenges of microbial identification by detecting and characterizing both known and previously unknown organisms found in a variety of specimens," Dr. Sundwall said. "The high-throughput technology offers our laboratory rapid detection and correct identification of a broad range of pathogens."

Dr. Sundwall added that for disease surveillance, the Plex-ID technology would enable public health officials to track emergent strains as they evolve, mutate, and possibly become more dangerous.

Abbott announced that the Utah Department of Health is one of five sites in the United States to participate in Abbott's new Plex-ID Biopreparedness Evaluation Program (BPEP), which involves Abbott, the Association of Public Health Laboratories (APHL; Silver Spring, MD, USA) and five state public health labs. The announcement was made at a ribbon-cutting ceremony for UDH's new multipurpose, state-of the-art Unified State Lab (USL; Taylorsville, UT, USA), a 7525 m2 facility that houses a variety of public-health laboratories.

In addition to Utah, the evaluation program will be conducted at state public health laboratories in Oklahoma, Minnesota, New York, and Virginia. In 2009, Plex-ID was recognized by both the Scientist and the Wall Street Journal as a top scientific innovation of the year.

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture, and marketing of medical products, diagnostics, and pharmaceutics.

Related Links:
Abbott
Utah Department of Health
Association of Public Health Laboratories
Unified State Lab


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.